1. Vitamin D Related/Nuclear Receptor
  2. VD/VDR
  3. VDR agonist 5

VDR agonist 5 是一种口服有效的 VDR 激动剂。VDR agonist 5 可激活 VDR 介导的信号通路以减缓肝纤维化进展。VDR agonist 5 不会诱发高钙血症。VDR agonist 5 可用于肝纤维化的相关研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

VDR agonist 5

VDR agonist 5 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

VDR agonist 5 is an oral active VDR agonist. VDR agonist 5 activates VDR-mediated signaling to reduce liver fibrosis progression. VDR agonist 5 does not induce hypercalcemia. VDR agonist 5 can be used for the research of hepatic fibrosis[1].

体外研究
(In Vitro)

VDR agonist 5 (Compound II-8) (0.5 μM) 在人肝星状细胞 LX-2 中发挥 VDR 激动剂作用,可显著上调 VDR 靶基因 CYP24A1 的表达水平[1]
VDR agonist 5 (0.01-1 μM; 48 h) 可激活 HEK293 细胞中 VDR 介导的转录,在 0.5 μM 时具有显著的反式激活活性,且在 0.01、0.1 和 1 μM 浓度范围内呈现剂量依赖性响应[1]
VDR agonist 5 (II-8) (0.5 μM; 24 h) 可抑制 TGF-β1 诱导的人肝星状细胞 LX-2 的活化,显著降低促纤维化标志物 α-SMA 和 I 型胶原蛋白的 mRNA 及蛋白表达,且活性可持续至少 48 小时[1]
VDR agonist 5 (0.5 μM; 24 h) 具有抗纤维化活性,可特异性抑制 TGF-β1 诱导的 LX-2 人肝星状细胞活化,该作用由维生素 D 受体介导,因为敲低 VDR 可显著降低其抑制 α-SMA 和 I 型胶原蛋白表达的能力[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: LX-2 human hepatic stellate cell line activated with TGF-β1
Concentration: 0.5 μM
Incubation Time: 24 h (post-siRNA transfection, alongside TGF-β1 activation)
Result: Significantly reduced TGF-β1-induced upregulation of α-SMA and collagen I protein expression compared to TGF-β1-only treated cells in siNC-transfected cells.
Markedly attenuated the ability to reduce α-SMA and collagen I protein expression in siVDR-transfected cells, with protein levels significantly increased compared to siNC-transfected cells treated with the target reagent and TGF-β1.
体内研究
(In Vivo)

VDR agonist 5 (Compound II-8) (500 μg/kg; p.o.; daily; 7 days) 可显著减轻雄性 C57BL/6 小鼠中 BDL 诱导的肝纤维化并恢复肝功能,且不会诱发高钙血症[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 (male, 8 weeks old, BDL-induced hepatic fibrosis)[1]
Dosage: 500 μg/kg
Administration: p.o.; daily; 7 days
Result: Significantly attenuated fibrotic lesions and reduced collagen I deposition (comparable to positive control calcipotriol).
Significantly downregulated hepatic mRNA expression of fibrosis-associated genes Timp-1, Ctgf, and Fn.
Significantly reduced hepatic protein levels of α-SMA, CTGF, and Fibronectin.
Significantly lowered serum levels of ALT, AST, and TBA.
Did not induce hypercalcemia (serum calcium levels remained comparable to control and untreated BDL mice).
分子量

510.66

Formula

C30H42N2O5

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
VDR agonist 5
目录号:
HY-181486
需求量: